You are here: Home / Sites / Mount Sinai Medical Center / Fishman, David

Fishman, David (M.D.)

PI, Mount Sinai Medical Center, 212-241-1901

Contact Information

EDRN Associate Member
Gynecologic Oncology

To update contact information, please visit the Data Management and Coordinating Center.

Open Protocols

Protocol Name Biomarkers Datasets
National Ovarian Cancer Early Detection Program Blood and Genetics 0 0

Closed Protocols

No closed protocols.


Publication Name PubMed ID Journal
Use of proteomic patterns in serum to identify ovarian cancer. 11867112 Lancet
Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer. 14506139 Clin. Cancer Res.
Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. 12235007 Cancer Res.
Evaluating the total costs of chemotherapy-induced toxicity: results from a pilot study with ovarian cancer patients. 11675522 Oncologist
[Lysophosphatidic acid as a potential target for treatment and molecular diagnosis of epithelial ovarian cancers]. 19739275 Orv Hetil
Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation. 11474660 N. Engl. J. Med.
The scientific basis of early detection of epithelial ovarian cancer: the National Ovarian Cancer Early Detection Program (NOCEDP). 11775458 Cancer Treat. Res.
Ultrasound and ovarian cancer. 11775447 Cancer Treat. Res.
BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer. 10739756 Am. J. Hum. Genet.
Autocrine regulation of growth stimulation in human epithelial ovarian carcinoma by serine-proteinase-catalysed release of the urinary-type-plasminogen-activator N-terminal fragment. 10417342 Biochem. J.
Is transvaginal ultrasound effective for screening asymptomatic women for the detection of early-stage epithelial ovarian carcinoma? 10831340 Gynecol. Oncol.
Methylation profiles of sporadic ovarian tumors and nonmalignant ovaries from high-risk women. 12429618 Clin. Cancer Res.
Localization of the activin signal transduction components in normal human ovarian follicles: implications for autocrine and paracrine signaling in the ovary. 12050229 J. Clin. Endocrinol. Metab.
Whole-abdominal radiation in endometrial carcinoma: an analysis of toxicity, patterns of recurrence, and survival. 11131490 Cancer J
Clinical implementation of soluble EGFR (sEGFR) as a theragnostic serum biomarker of breast, lung and ovarian cancer. 19431095 IDrugs
Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study. 11377596 Lancet
Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells. 11306508 Cancer Res.
Ovarian carcinoma regulation of matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase through beta1 integrin. 10197640 Cancer Res.
Three-dimensional power Doppler ultrasound improves the diagnostic accuracy for ovarian cancer prediction. 11426960 Gynecol. Oncol.

To update protocols, publications, biomarkers, or science data, please contact the Informatics Center.


1170 5th Avenue, Box 1176
New York University School of Medicine

To update addresses, please visit the Data Management and Coordinating Center.

Announcement 01/27/2020

Please visit the EDRN Registration page for registration/hotel information for the 35th EDRN Steering Committee Meeting from March 31-April 2, 2020, in Tempe, AZ.

This icon signifies that something is happening and we kindly ask you to please wait